23 May 2013
Keywords: ec, clears, b-ms, orencia, ra, european, commission
Article | 04 June 2007
The European Commission has granted approval of US drug major Bristol-Myers Squibb's Orencia (abatacept) for rheumatoid arthritis, a
disease that ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 June 2007
22 May 2013
© 2013 thepharmaletter.com